# OnCo record paper-ghsg-hd10-reduced-intensity-early-hodgkin-nejm-2010 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ghsg-hd10-reduced-intensity-early-hodgkin-nejm-2010/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ghsg-hd10-reduced-intensity-early-hodgkin-nejm-2010" ;
  schema:name "GHSG HD10: reduced treatment intensity in early-stage favourable Hodgkin lymphoma"@en ;
  schema:description "Two cycles of ABVD chemotherapy and a lower radiotherapy dose cured early favourable Hodgkin lymphoma as well as four cycles and a higher dose, so patients could be given less treatment and fewer late effects."@en ;
  schema:url <https://onco.cc/key-papers/paper-ghsg-hd10-reduced-intensity-early-hodgkin-nejm-2010/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1000067>, <https://pubmed.ncbi.nlm.nih.gov/20818855/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1000067> ;
  schema:datePublished "2010"^^xsd:gYear ;
  schema:author "Engert A, Plütschow A, Eich HT, et al." ;
  onco:cancers <https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/vinblastine/>, <https://onco.cc/drugs/dacarbazine/> ;
  onco:journals <https://onco.cc/journals/nejm/> .